Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Reactive Oxygen Species in Inflammation and Tissue Injury
2013 Standout
Quantitative Proteomics Identifies Serum Response Factor Binding Protein 1 as a Host Factor for Hepatitis C Virus Entry
2015 StandoutNobel
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines
2013 StandoutNobel
Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients
2000
RENAL DISEASE ASSOCIATED WITH HEPATITIS C INFECTION AFTER KIDNEY AND LIVER TRANSPLANTATION1
2000
Natural history of hepatitis C
1999
Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance
2018 StandoutNobel
Association of hepatitis C virus envelope proteins with exosomes
2004 StandoutNobel
Efficacy and safety of lamivudine in renal transplant patients with chronic hepatitis B
2000
Burden of liver diseases in the world
2018 Standout
Hepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A Systematic Review of Data for Scaling Up Treatment and Prevention
2014
Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies
2005
Chronic viral hepatitis and the human genome
2000
Entecavir Therapy for Adefovir-Resistant Hepatitis B Virus Infection in Kidney and Liver Allograft Recipients
2008
The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes
2001 StandoutNobel
Genetics of susceptibitlity to human infectious disease
2001
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
2010 StandoutNobel
Hepatitis C infection and the patient with end-stage renal disease
2002
Viral Infection in the Renal Transplant Recipient
2005
HBV GENOTYPIC RESISTANCE TO LAMIVUDINE IN KIDNEY RECIPIENTS AND HEMODIALYZED PATIENTS
2000
Chronic viral hepatitis in hemodialysis patients
2005
Natural history of chronic hepatitis C
2002
Patient HLA-DRB1* and -DQB1* allele and haplotype association with hepatitis C virus persistence and clearance
2010
Immunology of hepatitis B virus and hepatitis C virus infection
2005 Standout
Histopathologic Efficacy of Ribavirin Monotherapy in Kidney Allograft Recipients with Chronic Hepatitis C
2004
Interferon α–Stimulated Natural Killer Cells From Patients With Acute Hepatitis C Virus (HCV) Infection Recognize HCV-Infected and Uninfected Hepatoma Cells via DNAX accessory molecule-1
2012 StandoutNobel
A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation
1998
Outcomes After Lung Transplantation in Patients With Chronic Hepatitis C Virus Infection
2007
Chronic hepatitis B treatment with lamivudine in kidney transplant patients
2000
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Q-fever and autoimmunity
1989
Management of chronic viral hepatitis before and after renal transplantation
2002
Treatment of Hepatitis C in Potential Lung Transplant Candidates
2007
Lamivudine Therapy in Kidney Allograft Recipients Who Are Seropositive for Hepatitis B Surface Antigen
2006
Chronic hepatitis C virus infection in renal transplant: treatment and outcome
2006
Natural and iatrogenic variation in hepatitis B virus
1999
Management of Hepatocellular Carcinoma *
2005 Standout
Management of pediatric postrenal transplantation infections
2001
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: meta-analysis of clinical trials
2004
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis c
2004
Randomized trial of pegylated interferon α-2b monotherapy in haemodialysis patients with chronic hepatitis C
2005
INTERFERON-?? TREATMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN RECIPIENTS OF SOLID ORGAN TRANSPLANTS1
1998
Efficacy and tolerance of interferon-α2b in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment
1999
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
2012 Standout
Hepatitis C virus: Prevention, screening, and interpretation of assays
2010
CD4 T Lymphocyte Proliferative Responses to Hepatitis C Virus (HCV) Antigens in Patients Coinfected with HCV and Human Immunodeficiency Virus Who Responded to Anti‐HCV Treatment
2002 StandoutNobel
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
2013 StandoutNobel
Protective Immunity Against Hepatitis C: Many Shades of Gray
2014
Managing hepatitis B reactivation in renal transplant recipients: a 12-year review with emphasis on early detection and early use of lamivudine
2000
Chronic hepatitis B
2007 Standout
Management of hepatitis C
2003
Chronic hepatitis B: Update 2009 #
2009 Standout
American Gastroenterological Association Technical Review on the Management of Hepatitis C
2006
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Acute hepatitis C without and with schistosomiasis: Correlation with hepatitis C–Specific CD4+ T-cell and cytokine response
2001
Treatment of chronic hepatitis B with lamivudine in renal allograft recipients
2000
Hepatitis C and renal disease: an update
2003
Stable Cytotoxic T Cell Escape Mutation in Hepatitis C Virus Is Linked to Maintenance of Viral Fitness
2008 StandoutNobel
Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome
2008
Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity
1998
Hepatitis C virus: How genetic variability affects pathobiology of disease
2011
Normal Functional Capacity in Circulating Myeloid and Plasmacytoid Dendritic Cells in Patients with Chronic Hepatitis C
2005 StandoutNobel
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Hepatitis C Infection, Time in Renal-Replacement Therapy, and Outcome after Kidney Transplantation
2004
Chronic Active Hepatitis B Exacerbations in Human Immunodeficiency Virus‐Infected Patients Following Development of Resistance to or Withdrawal of Lamivudine
1999
Outcome of renal transplantation in hepatitis B surface antigen‐positive patients after introduction of lamivudine†
2001
Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment
2011
TWELVE MONTHS OF LAMIVUDINE TREATMENT FOR CHRONIC HEPATITIS B VIRUS INFECTION IN RENAL TRANSPLANT RECIPIENTS12
2000
Hepatitis C virus and interferon resistance
2000
Leprosy
2004 Standout
Meta‐analysis: interferon for the treatment of chronic hepatitis C in dialysis patients
2003
Interferon gamma‐1b for the treatment of fibrosis in chronic hepatitis C infection
2006
Lamivudine in recurrent hepatitis B after renal transplantation
2001
Interferon Monotherapy for Dialysis Patients With Chronic Hepatitis C: An Analysis of The Literature on Efficacy and Safety
2003
Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients
2002
Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection
2001
Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis
2006
Prospective Study on Lamivudine-Resistant Hepatitis B in Renal Allograft Recipients
2004
Infection in Solid-Organ Transplant Recipients
2007 Standout
Pathogenesis, diagnosis and management of hepatitis C
2000
Efficacy and tolerance of interferon‐α in the treatment of chronic Hepatitis C in end‐stage renal disease patients on hemodialysis
2006
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
CD4+ T cell responses in hepatitis C virus infection
2007
Treatment of HCV in Patients with Renal Failure
2007
Efficacy and tolerability of pegylated‐interferon alpha‐2a in hemodialysis patients with chronic hepatitis C
2005
Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B
2004
Successful treatment of hepatitis C after kidney transplantation with combined interferon alpha-2b and ribavirin
2003
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients
2001
RESULTS ON PREEMPTIVE OR PROPHYLACTIC TREATMENT OF LAMIVUDINE IN HBsAg (+) RENAL ALLOGRAFT RECIPIENTS: COMPARISON WITH SALVAGE TREATMENT AFTER HEPATIC DYSFUNCTION WITH HBV RECURRENCE
2001
Natural history of hepatitis C
2014
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
The immunobiology of schistosomiasis
2002 Standout
Epstein–Barr Virus Infection
2000 Standout
Replication of hepatitis C virus
2007 StandoutNobel
TREATMENT OF CHRONIC HEPATITIS B WITH LAMIVUDINE IN RENAL TRANSPLANT RECIPIENTS1
1998
Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates
2000 StandoutNobel
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Polymorphisms in melanoma differentiation‐associated gene 5 link protein function to clearance of hepatitis C virus
2014 StandoutNobel
Long-Term Lamivudine Monotherapy in Renal-Transplant Recipients with Hepatitis-B-Related Cirrhosis
2005
End-stage renal disease and hepatitis C infection: comparison of alanine aminotransferase levels and liver histology in patients with and without renal damage
2007
Long-Term Outcome of Renal Transplant Recipients With Chronic Hepatitis B Infection—Impact of Antiviral Treatments
2010
EASL Clinical Practice Guidelines on hepatitis E virus infection
2018
Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection
2014
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner
2004 StandoutNobel
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Q Fever
1999 Standout
Treatment of Hepatitis C Virus Infection (HCV) After Renal Transplantation: Implications for HCV-Positive Dialysis Patients Awaiting a Kidney Transplant
2006
Lamivudine therapy for hepatitis B in renal transplantation
2002
Macrophages and Tissue Injury: Agents of Defense or Destruction?
2011
Kinetics of CD4+and CD8+Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees
2003 StandoutNobel
Quasispecies Heterogeneity within the E1/E2 Region as a Pretreatment Variable during Pegylated Interferon Therapy of Chronic Hepatitis C Virus Infection
2005
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Viral Determinants of Resistance to Treatment in Patients with Hepatitis C
2007
Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome
2002
A Common Dominant TLR5 Stop Codon Polymorphism Abolishes Flagellin Signaling and Is Associated with Susceptibility to Legionnaires' Disease
2003 StandoutNobel
Hepatitis C and liver transplantation
2001
P2X7Receptor Activation in Rat Brain Cultured Astrocytes Increases the Biosynthetic Release of Cysteinyl Leukotrienes
2005
RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase
2013 StandoutNobel
Rituximab Therapy for De Novo Mixed Cryoglobulinemia in Renal Transplant Patients
2005
Is alanine aminotransferase a good marker of histologic hepatic damage in renal transplant patients with hepatitis C virus infection?
2005
Two Successive Hepatitis C Virus Infections in an Intravenous Drug User
2000
New Natural Intergenotypic (2/5) Recombinant of Hepatitis C Virus
2007
Cell-Mediated Immunity and the Outcome of Hepatitis C Virus Infection
2004
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
2000
Hepatitis C in Children
2006
Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response
2022 StandoutNobel
Natural history of chronic hepatitis C
2002
Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity
2001 StandoutNobel
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel
Works of M Duffaut being referenced
Maintenance therapy with gradual reduction of the interferon dose over one year improves histological response in patients with chronic hepatitis C with biochemical response: results of a randomized trial
2001
TREATMENT OF CHRONIC HEPATITIS C WITH RECOMBINANT INTERFERON ALPHA IN KIDNEY TRANSPLANT RECIPIENTS
1995
Study of host‐ and virus‐related factors associated with spontaneous hepatitis C virus clearance
2000
Serological Markers of Autoimmunity in Renal Transplant Patients with Chronic Hepatitis C
1998
High Rate of Hepatitis C Virus Clearance in Hemodialysis Patients after Interferon‐α Therapy
1997
IMPACT OF HEPATITIS C VIRUS DURATION AND HEPATITIS C VIRUS GENOTYPES ON RENAL TRANSPLANT PATIENTS
1998
Involvement of calcium in macrophage leukotriene release during experimental cirrhosis
1996
Reactive oxygen intermediates and eicosanoid production by Kupffer cells and infiltrated macrophages in acute and chronic liver injury induced in rats by CCl 4
2000
Longitudinal Analysis of Hepatitis C Virus Replication and Liver Fibrosis Progression in Renal Transplant Recipients
2000
EFFICACY AND SAFETY OF LAMIVUDINE ON REPLICATION OF RECURRENT HEPATITIS B AFTER CADAVERIC RENAL TRANSPLANTATION
1997
Epidemiology of HCV infection: disease and renal transplantation
1996
Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection
1997
Preliminary results of treatment of chronic hepatitis C with recombinant interferon alpha in renal transplant patients
1995
Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection
2002
Study of the association between major histocompatibility complex class II genes and the response to interferon alpha in patients with chronic hepatitis C infection
1999
Effects of long-term lamivudine therapy in renal-transplant patients
2004
Genetic Heterogeneity of Hypervariable Region 1 of the Hepatitis C Virus (HCV) Genome and Sensitivity of HCV to Alpha Interferon Therapy
2000
Treatment of chronic hepatitis C with recombinant alpha 2b interferon in kidney transplant recipients: preliminary results and side effects.
1995
[Circulating anticoagulant during primosecondary syphilis and Q fever].
1981
[HCV RNA clearance after treatment with interferon-alpha in chronic hemodialysis patients with or without coinfection by HGV/HGBV-C].
1997